Zyprexa Zydis

   
Google
 
Web NewDrugInformation.com

Zyprexa Zydis


Drug - Zyprexa Zydis
The trade name of the product as shown on the labeling.

Dosage - TABLET, ORALLY DISINTEGRATING; ORAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Olanzapine
Multiple ingredients are in alphabetical order.

Strength - 20MG
The potency of the active ingredient(s), Olanzapine. May repeat for multiple part products.

Applicant - LILLY
The firm name holding legal responsibility for Zyprexa Zydis. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 021086
The FDA assigned number to Zyprexa Zydis. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Zyprexa Zydis. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Apr 6, 2000
The date Zyprexa Zydis was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Zyprexa Zydis. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - RX
The group or category of approved drugs Zyprexa Zydis is in. Format is RX, OTC, DISCN.

Applicant Full Name - Eli Lilly And Co
The full name of the firm holding legal responsibility for the new application of Zyprexa Zydis.

Zyprexa Zydis